🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I study to evaluate the safety, tolerability and pharmacoki...
Status
Completed
Location
Christchurch Clinical Studies Trust
Start Date
2015-11-26
Trial ID
NCT02574091
Treatments Being Tested
Phase II Study of Icotinib Hydrochloride in Treating Patients With Recurren...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2013-10
Trial ID
NCT01973725
Treatments Being Tested
1)Preliminarily evaluate the treatment effect of Icotinib Hydrochloride Tab...
Status
Completed
Location
Beijing Tiantan Hospital Affiliated to Capital Medical University
Start Date
2016-07
Trial ID
NCT02934256
Treatments Being Tested
The investigators performed a randomized, double blind controlled, prospect...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02889692
Treatments Being Tested
To assess the efficacy and safety of D-0316 versus Icotinib, a standard of ...
Status
Completed
Location
The First Affiliated Hospital of Medical School of Zhejiang University
Start Date
2019-12-24
Trial ID
NCT04206072
Treatments Being Tested
This study is a prospective, multicenter, real-world study to investigate t...
Status
Unknown
Location
Guangdong Provincial People's Hospital
Start Date
2020-10-07
Trial ID
NCT04575415
Treatments Being Tested
Objective: To compare the efficacy and safety of chemotherapy plus intercal...
Status
Unknown
Location
Yu Li
Start Date
2014-01
Trial ID
NCT02031601
Concurrent chemoradiotheray is the standard care for patients with locally ...
Status
Unknown
Location
Hangzhou Cancer Hospital
Start Date
2012-01
Trial ID
NCT02738983
Treatments Being Tested
This single-arm pilot study tries to invesitgate how well giving icotinib w...
Status
Unknown
Location
Zhejiang University
Start Date
2015-03
Trial ID
NCT02375022
Treatments Being Tested
A single arm study: EGFR-TKIs Combine With Anlotinib as First-line Treatmen...
Status
Unknown
Location
Fujian cancer hospital
Start Date
2018-10
Trial ID
NCT03720873
Treatments Being Tested